| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide the use of one or more cannabinoids in the manufacture of medicaments for use in the treatment of diseases and conditions benefiting from neutral antagonism of the CB, a cannabinoid receptor. <P>SOLUTION: Tetrahydrocannabivaline (THCV) is used in the treatment of obesity, schizophrenia, epilepsy, cognitive disorders such as Alzheimer's disease, bone disorders, bulimia, obesity associated with type II diabetes (non-insulin dependant diabetes), and drug, alcohol and nicotine abuse or dependency. <P>COPYRIGHT: (C)2012,JPO&INPIT |
